Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
inhibits FL T3 mutations
|
| gptkbp:appointed_by |
oral tablet
|
| gptkbp:clinical_trial |
Phase 2
|
| gptkbp:developed_by |
gptkb:Astellas_Pharma
|
| https://www.w3.org/2000/01/rdf-schema#label |
Quizartinib
|
| gptkbp:ingredients |
C22 H24 Cl N5 O2 S
|
| gptkbp:is_used_for |
treatment of acute myeloid leukemia
|
| gptkbp:status |
investigational drug
|
| gptkbp:targets |
FL T3 receptor
|
| gptkbp:type |
tyrosine kinase inhibitor
|
| gptkbp:type_of |
1234567-89-0
|
| gptkbp:bfsParent |
gptkb:Genzyme_Genetics
|
| gptkbp:bfsLayer |
5
|